- Home
- YYGH vs INO Comparison
YYGH vs INO Comparison
Compare YYGH & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYGH
- INO
- Stock Information
- Founded
- YYGH 2010
- INO 1979
- Country
- YYGH Singapore
- INO United States
- Employees
- YYGH N/A
- INO N/A
- Industry
- YYGH
- INO Medical/Dental Instruments
- Sector
- YYGH
- INO Health Care
- Exchange
- YYGH NYSE
- INO Nasdaq
- Market Cap
- YYGH 69.2M
- INO 75.4M
- IPO Year
- YYGH 2024
- INO 1998
- Fundamental
- Price
- YYGH $1.77
- INO $2.08
- Analyst Decision
- YYGH
- INO Buy
- Analyst Count
- YYGH 0
- INO 6
- Target Price
- YYGH N/A
- INO $17.00
- AVG Volume (30 Days)
- YYGH 66.0K
- INO 1.2M
- Earning Date
- YYGH 02-21-2025
- INO 03-05-2025
- Dividend Yield
- YYGH N/A
- INO N/A
- EPS Growth
- YYGH 527.44
- INO N/A
- EPS
- YYGH 0.04
- INO N/A
- Revenue
- YYGH $37,372,731.00
- INO $203,413.00
- Revenue This Year
- YYGH N/A
- INO N/A
- Revenue Next Year
- YYGH N/A
- INO $2,290.97
- P/E Ratio
- YYGH $43.96
- INO N/A
- Revenue Growth
- YYGH 55.18
- INO N/A
- 52 Week Low
- YYGH $0.72
- INO $1.74
- 52 Week High
- YYGH $4.70
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- YYGH N/A
- INO 39.63
- Support Level
- YYGH N/A
- INO $1.83
- Resistance Level
- YYGH N/A
- INO $2.39
- Average True Range (ATR)
- YYGH 0.00
- INO 0.17
- MACD
- YYGH 0.00
- INO 0.11
- Stochastic Oscillator
- YYGH 0.00
- INO 51.56
About YYGH YY GROUP HOLDING LIMITED
YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.